Your browser doesn't support javascript.
loading
Effects of topical application of tramadol with/without dexmedetomidine and proparacaine on corneal sensitivity in rats.
Lelescu, Cristina A; Dumitras, Daria A; Iurian, Sonia; Staffieri, Francesco; Muresan, Cosmin.
Afiliación
  • Lelescu CA; Modis Competence Center, Modis Life Sciences Belgium, Mureșului 9, 400000, Cluj-Napoca, Romania.
  • Dumitras DA; Department of Biochemistry, Faculty of Veterinary Medicine, University of Agricultural Sciences and Veterinary Medicine, Calea Manastur 3-5, 400372, Cluj-Napoca, Romania.
  • Iurian S; Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, University of Medicine and Pharmacy "Iuliu Hațieganu", V. Babeș 41, 400012, Cluj-Napoca, Romania.
  • Staffieri F; Division of Veterinary Surgery, Department of Emergency and Organ Transplantation, Faculty of Veterinary Medicine, University "Aldo Moro" of Bari, SP Per Casamassima Km. 3, 70010, Valenzano, Bari, Italy.
  • Muresan C; Department of Surgery, Faculty of Veterinary Medicine, University of Agricultural Sciences and Veterinary Medicine, Calea Manastur 3-5, 400372, Cluj-Napoca, Romania. muresanscosmin@gmail.com.
Int Ophthalmol ; 41(2): 465-473, 2021 Feb.
Article en En | MEDLINE | ID: mdl-33095346
ABSTRACT

PURPOSE:

To evaluate the corneal anesthetic effect following topical application of tramadol alone and in combination with dexmedetomidine, and compare it to proparacaine, in clinically healthy rats.

METHODS:

A randomized, crossover study was performed. Twenty Wistar albino rats (n = 40 eyes) were used. Corneal touch threshold (CTT) measurements (in mm) were obtained using a Cochet-Bonnet aesthesiometer. CTT measurements were obtained at baseline, 1-min following application of the topical anesthetic agent, and repeated at 5-min intervals up to 75 min. The topical protocol involved 3 treatment conditions, separated by a 2-week washout period proparacaine, tramadol alone, and tramadol in combination with dexmedetomidine.

RESULTS:

CTT values were significantly decreased compared to baseline at each timepoint until completion of the 75-min evaluation in all treated eyes, regardless of the assigned treatment (p < 0.0083). With tramadol, complete corneal anesthesia (CTT = 0) was achieved within 1-5 min in 18 eyes and ranged from 5 to 25 min. Co-administration of dexmedetomidine to tramadol resulted in significantly increased CTT values from 5 to 20 min following topical application, compared to tramadol alone (p < 0.0083), and complete corneal anesthesia was achieved in only 14 out of 20 treated eyes.

CONCLUSION:

Tramadol might be a useful alternative to topical anesthetic agents, providing a dose-related corneal anesthetic effect. Co-administration of dexmedetomidine does not potentiate its anesthetic effect. The underlying mechanism(s) of drug antagonism between tramadol and dexmedetomidine remains to be determined.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tramadol / Dexmedetomidina Tipo de estudio: Diagnostic_studies / Guideline Límite: Animals Idioma: En Revista: Int Ophthalmol Año: 2021 Tipo del documento: Article País de afiliación: Rumanía Pais de publicación: HOLANDA / HOLLAND / NETHERLANDS / NL / PAISES BAJOS / THE NETHERLANDS

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tramadol / Dexmedetomidina Tipo de estudio: Diagnostic_studies / Guideline Límite: Animals Idioma: En Revista: Int Ophthalmol Año: 2021 Tipo del documento: Article País de afiliación: Rumanía Pais de publicación: HOLANDA / HOLLAND / NETHERLANDS / NL / PAISES BAJOS / THE NETHERLANDS